Anlageziel

The Fund seeks to maximise total return by investing at least 80% of its total assets in the equity securities of companies globally that are involved with new and emerging themes in health care. In normal market conditions the Fund will invest in a portfolio of equity securities of companies with large, medium and small market capitalisation across multiple industries including (without limitation) biotechnology, pharmaceuticals, life sciences tools and services, health care technology, health care equipment, medical devices and digital health care, and across multiple sub-themes including (without limitation) the following: genetic medicine, next generation diagnostics, immunotherapy, robotic-assisted surgery, biosensors and trackers, medical artificial intelligence applications and telehealth.